A sustainable and expedited ‘One‐Stop’ prostate cancer diagnostic pathway to reduce environmental impact and enhance accessibility

Documenti analoghi

• Does bladder outflow obstruction obfuscate the traditional clinical factors that are used to assess the risk of prostate cancer at rapid‐access diagnostic clinics?
  di: Thomas Philip Cahill, et al.
  Pubblicazione: (2024)
• Cost‐effectiveness analysis of a biopsy‐free diagnostic strategy for prostate cancer using mpMRI and PSMA‐PET/CT
  di: Joshua Yi Min Tung, et al.
  Pubblicazione: (2026)
• Computerized tomography‐derived body composition metrics are associated with 24‐h urine lithogenic parameters
  di: Reza Lahiji, et al.
  Pubblicazione: (2026)
• Perioperative antibiotic prophylaxis, prostate size and transperineal prostate biopsy
  di: Maxwell Louis Sandberg, et al.
  Pubblicazione: (2026)
• Genomic prostate score and treatment selection in favourable intermediate‐risk prostate cancer
  di: Eric Margolis, et al.
  Pubblicazione: (2025)